JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

F Zoulim; O Lenz; JJ Vandenbossche; W Talloen; T Verbinnen; I Moscalu; A Streinu-Cercel; S Bourgeois; M Buti; J Crespo; JM Pascasio; C Sarrazin; Thomas Vanwolleghem; U Shukla; J Fry; JZ Yogaratnam

doi:10.1053/j.gastro.2020.04.036

JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

F Zoulim, O Lenz, JJ Vandenbossche, W Talloen, T Verbinnen, I Moscalu, A Streinu-Cercel, S Bourgeois, M Buti, J Crespo, JM Pascasio, C Sarrazin, Thomas Vanwolleghem, U Shukla, J Fry, JZ Yogaratnam

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

62 Citations (Scopus)

Original language	English
Pages (from-to)	521-+
Journal	Gastroenterology
Volume	159
Issue number	2
DOIs	https://doi.org/10.1053/j.gastro.2020.04.036
Publication status	Published - 2020

Access to Document

10.1053/j.gastro.2020.04.036

http://hdl.handle.net/1765/129699

Cite this

Zoulim, F., Lenz, O., Vandenbossche, JJ., Talloen, W., Verbinnen, T., Moscalu, I., Streinu-Cercel, A., Bourgeois, S., Buti, M., Crespo, J., Pascasio, JM., Sarrazin, C., Vanwolleghem, T., Shukla, U., Fry, J., & Yogaratnam, JZ. (2020). JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection. Gastroenterology, 159(2), 521-+. https://doi.org/10.1053/j.gastro.2020.04.036

@article{8430516a925f41ef9e7fa616ce2b087e,

title = "JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection",

author = "F Zoulim and O Lenz and JJ Vandenbossche and W Talloen and T Verbinnen and I Moscalu and A Streinu-Cercel and S Bourgeois and M Buti and J Crespo and JM Pascasio and C Sarrazin and Thomas Vanwolleghem and U Shukla and J Fry and JZ Yogaratnam",

year = "2020",

doi = "10.1053/j.gastro.2020.04.036",

language = "English",

volume = "159",

pages = "521--+",

journal = "Gastroenterology",

issn = "0016-5085",

number = "2",

}

Zoulim, F, Lenz, O, Vandenbossche, JJ, Talloen, W, Verbinnen, T, Moscalu, I, Streinu-Cercel, A, Bourgeois, S, Buti, M, Crespo, J, Pascasio, JM, Sarrazin, C, Vanwolleghem, T, Shukla, U, Fry, J & Yogaratnam, JZ 2020, 'JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection', Gastroenterology, vol. 159, no. 2, pp. 521-+. https://doi.org/10.1053/j.gastro.2020.04.036

TY - JOUR

T1 - JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

AU - Zoulim, F

AU - Lenz, O

AU - Vandenbossche, JJ

AU - Talloen, W

AU - Verbinnen, T

AU - Moscalu, I

AU - Streinu-Cercel, A

AU - Bourgeois, S

AU - Buti, M

AU - Crespo, J

AU - Pascasio, JM

AU - Sarrazin, C

AU - Vanwolleghem, Thomas

AU - Shukla, U

AU - Fry, J

AU - Yogaratnam, JZ

PY - 2020

Y1 - 2020

U2 - 10.1053/j.gastro.2020.04.036

DO - 10.1053/j.gastro.2020.04.036

M3 - Article

SN - 0016-5085

VL - 159

SP - 521-+

JO - Gastroenterology

JF - Gastroenterology

IS - 2

ER -